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Since 7SK was discovered as an abundant small
nuclear RNA in the mid-70s, its role has remained
tantalizingly unsolved. Two recent studies have
shown that 7SK acts as a negative regulator of the
RNA polymerase II elongation factor P-TEFb, and
that this activity is influenced by stress response
pathways.
The ‘RNA world’ is a continuing source of surprises,
with frequent discoveries being reported of new roles
for RNA molecules and RNA–protein complexes. The
nuclei of eukaryotic cells contain a large set of stable
small RNAs, many of which have extensively studied
roles in different RNA processing events. These
include the major and minor uracil-rich small nuclear
RNAs (U snRNAs), which function in pre-mRNA splic-
ing in the nucleoplasm, and major and minor small
nucleolar RNAs (snoRNAs), which function to cleave
and modify pre-rRNA molecules in nucleoli. Among
the abundant snRNAs, 7SK has stood out as some-
thing of a sore thumb since its discovery by Zieve and
Penman in 1976 [1]. Despite the many intervening
years of effort towards understanding its biogenesis
and structural features [2–6], its function has long
remained a mystery. 
Now, two groups have found that 7SK functions as
a negative regulator of the transcription elongation
factor P-TEFb [7,8]. P-TEFb is a heterodimer of cyclin-
dependent kinase-9 (Cdk9) and one of several cyclins
— including cyclins T1, T2 and K — which activates
transcription by phosphorylating the carboxy-terminal
domain (CTD) of RNA polymerase II, leading to more
processive transcription complexes (reviewed in [9]).
P-TEFb has been shown to function as a general
elongation factor, as well as to facilitate the ability of
the HIV-1 Tat transactivator to promote transcription
from the HIV-1 long-terminal repeat (LTR) promoter.
The discovery that 7SK is a negative regulator of P-
TEFb, besides uncovering a completely unexpected
role for this snRNA, has provided the foundation for
understanding a new mechanism underlying the
control of cellular and viral genes.
The breakthrough came when Zhao, Bensaude and
their colleagues [7,8] were studying the composition
of P-TEFb complexes, with the aim of identifying inter-
acting factors that might help understand its role in
the regulation of RNA polymerase II transcription.
Zhao and colleagues [8] used a stable cell line
expressing Flag epitope-tagged Cdk9 to affinity-purify
associated factors, whereas Bensaude and colleagues
[7] were investigating the composition of P-TEFb-con-
taining complexes separated in glycerol gradients,
where complexes of two distinct sizes were detected.
The elution of complexes from the Flag–Cdk9 affinity
column resulted in the appearance of an oddly-stain-
ing band, yellowish in comparison to the more normal
brownish appearance of silver-stained proteins [8].
Yang et al. [8] surmised that the band might be com-
posed of nucleic acid and, sure enough, RNase A
treatment wiped the band from the gel. Meanwhile,
Nguyen et al. [7] found that treatment of their larger P-
TEFb-containing complex with RNase A converted it
to the size of the smaller complex. 
Both groups went on to characterize the size and
sequence of the co-purifying RNA, leading them to
identify 7SK as a component of the P-TEFb complex
[7,8]. This stage of the work has an important message
for anyone engaged in the analysis of multisubunit
complexes, especially in the burgeoning field of pro-
teomics. Off-color bands in silver-stained gels, or
bands that are refractory to identification by mass-
spectrometry methods, could represent nucleic acid
components and this should be tested for — they
could hold the next surprise from the RNA world!
The next step for both groups was to understand
the functional significance of the interaction between
7SK and P-TEFb. Nguyen et al. [7] observed that the
larger of the two P-TEFb complexes — sedimenting at
400–500 kDa, compared with the smaller complex
which sedimented at <130 kDa — was significantly
less active in phosphorylating a CTD peptide than the
smaller complex [7]. Separation of the complexes
incorporating an HA-tagged cyclin T1 subunit, followed
by immunoprecipitation with an anti-HA antibody,
allowed the specific kinase activity of the two com-
plexes to be compared. The authors estimated that
the small complex was approximately 15 times more
active than the large complex. 
Both groups additionally found that treatments to
release 7SK from immunopurified complexes, including
high salt or RNase A, increased the specific activity of
the bound Cdk9 kinase, as measured by its ability to
phosphorylate the RNA polymerase II CTD or a CTD
peptide. These results suggested that the association
of 7SK with P-TEFb was acting to suppress the activ-
ity of the Cdk9 kinase subunit. The next step was to
determine whether 7SK’s ability to inhibit the kinase
activity of P-TEFb is important for the regulation of
transcription.
Yang et al. [8] took advantage of an arsenal of
methods used previously to study snRNPs involved in
pre-mRNA splicing. An antisense biotinylated 2′-O-
methyl RNA oligonucleotide directed to 7SK snRNA
was used to deplete the particle from HeLa nuclear
extract. Depletion of 7SK — resulting in ~50% deple-
tion of cyclin T1 and Cdk9 — did not alter transcription
levels either proximal or distal to the HIV-1 LTR pro-
moter. But consistent with the observation that
release of 7SK from the P-TEFb heterodimer was
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associated with an increase in Cdk9 kinase activity,
specific cleavage of 7SK by oligonucleotide-directed
RNase H, which released the Ckd9–cyclin T1 het-
erodimer from the cleaved 7SK RNA, resulted in an
increase in both basal and Tat-activated transcription
from the HIV-1 promoter [8].
In an elegant follow-up experiment, it was demon-
strated that transfection of cells with DNA oligonu-
cleotides targeted to different regions of 7SK, which
direct RNaseH cleavage of 7SK in vivo, resulted in 
an increase in transcription from a co-transfected
luciferase reporter [8]. An increase was observed for
several different promoters, where the strongest
release from inhibition was observed from the HIV-1
LTR promoter. The greater sensitivity of the HIV-1 LTR
promoter to 7SK inhibition is probably due to the fact
that it is primarily regulated at the level of elongation,
and that it requires P-TEFb for both basal and Tat-
activated transcription.
It was next determined whether 7SK can cause
reduced levels of transcription by preventing the 
association of the P-TEFb heterodimer with the HIV-1
LTR promoter, as well as by reducing Cdk9 kinase
activity (Figure 1). In this experiment, the level of 7SK
in complexes formed on an immobilized HIV-1 pro-
moter was compared with the level of 7SK associated
with total P-TEFb affinity purified from HeLa nuclear
extract [8]. Strikingly, no 7SK was detected in associ-
ation with the promoter. A chromatin immunoprecip-
itation assay was used to analyze complexes
containing Cdk9–Flag protein assembled on a stably
integrated HIV-1 promoter. The level of LTR promoter
sequences recovered on Cdk9–Flag beads was found
to increase significantly when cells were co-trans-
fected with a DNA oligonucleotide that results in
cleavage and release of 7SK from P-TEFb. These
results show that 7SK reduces transcription levels by
preventing the kinase activity of P-TEFb as well as
reducing its ability to associate with a promoter
(Figure 1).
An important question raised by both the new
studies [7,8] is the physiological relevance of the
interaction between 7SK and the P-TEFb heterodimer.
A clue to this came from earlier studies on HIV-1
transcription, which showed that stress treatments
such as UV irradiation or low levels of the transcrip-
tional inhibitor actinomycin D can cause an increase in
HIV-1 transcription to levels similar to those promoted
by the Tat transactivator [10,11]. As P-TEFb is impor-
tant for Tat transactivation, and so could be involved
in the stress-induced increase in HIV-1 transcription,
both groups [7,8] speculated that stress treatments
might result in the release of 7SK from the P-TEFb
heterodimer, thereby increasing the fraction of tran-
scriptionally active P-TEFb. 
This was indeed found to be the case. UV irradiation
and actinomycin D were both found to cause rapid
release of 7SK from P-TEFb (Figure 1). The increased
transcription from the HIV-1 promoter following induc-
tion of stress pathways thus most likely involves the
dissociation of 7SK from P-TEFb. Such a mechanism
could play an important role in controlling escape
from viral latency and offers interesting new possibili-
ties for the design of RNA-based therapeutics that
might reduce or prevent escape from latency.
After stress treatments, transcription increases from
many cellular promoters in addition to the HIV-1
promoter, and the findings of both groups [7,8] point
to an important role for 7SK in modulating stress-
response pathways. It will be of interest to determine
which genes are most influenced by disruption of the
7SK–Cdk9–cyclin interaction. Moreover, an important
next step in these studies will be to determine the
nature of the contacts between 7SK and the
Cdk9–cyclin heterodimer, and which factor(s) modu-
late this interaction in response to stress treatments.
Finally, it will be of considerable interest to determine
whether the level and/or accessibility of 7SK snRNA is
altered as a means by which transcriptional levels are
regulated. Such a mechanism could be important
during specific stages of the cell cycle or during cellu-
lar differentiation.
A role for trans-acting RNAs in the regulation of
transcription is not unprecedented. In recent years
several interesting examples of this have emerged.
For example, non-coding RNAs such as Xist and 
roX have been identified which function in dosage
compensation by binding to chromatin or chromatin
regulators (reviewed in [12,13]). In striking analogy
with 7SK, a small RNA (6S RNA) identified three
decades ago in the bacterium Escherichia coli
recently returned to the spotlight when it was discov-
ered to negatively regulate transcription promoted by
the RNA polymerase σ70 subunit, which is required for
promoter recognition and transcriptional initiation and
is essential for normal growth [14]. During periods of
nutrient starvation and other types of cell stress,
another sigma factor, σS, is used to switch on genes
important for survival. Under these conditions, 6S
RNA interacts with the σ70 and β/β′ subunits of 
the E.coli polymerase, preventing transcription from 
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Figure 1. 7SK and cell stress.
Role of the 7SK snRNA in the regulation of transcription.
P-TEFb, a heterodimer consisting of Cdk9 — the RNA poly-
merase II carboxy-terminal domain (CTD) kinase — and one of
several cyclin subunits — T1, T2 or K — promotes transcription
elongation by increasing the phosphorylation of the RNA poly-
merase II CTD, which leads to more processive transcription
complexes. 7SK interacts with a population of P-TEFb, inhibit-
ing its CTD kinase activity as well as its ability to associate with
transcription complexes. Induction of stress response path-
ways results in disruption of the P-TEFb–7SK interaction and a
consequent increase in the population of active P-TEFb. 7SK
may therefore play an important role in the regulation of gene












σ70-dependent promoters, thereby causing a shift to 
σS-mediated transcription. 
A role for small RNAs in regulating transcriptional
activity is thus a conserved feature in evolution.
Together, the studies described above present an
interesting question: what other small RNAs, besides
7SK and 6S might function to regulate transcriptional
activity? If past experience is any indicator, themes in
gene regulation tend to be repeated and these small
RNAs are probably not alone in their ability to function
at the level of transcription.
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